Establish self-regulatory body to maintain pharma products quality: Dr Mansukh Mandaviya urges industry Ruchika Sharma24 Jun 2023 1:30 PM ISTMinister said that the country is marching ahead in the field of research and innovation as the government has opened its research facilities to all...
Dr Reddy's Labs gets CDSCO panel nod to manufacture, market Ferric Carboxymaltose Inj to treat iron deficiency Susmita Roy20 Jun 2023 5:07 PM ISTNew Delhi: In a significant development, Dr. Reddy's Laboratories has got a go-ahead from the Subject Expert Committee (SEC) functional under the...
Revise Phase IV clinical trial protocol of Nimesulide Granules for oral suspension: CDSCO Panel Tells Dr Reddys Dr. Divya Colin18 Jun 2023 11:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has recommended the drug major Dr....
USFDA inspection: Dr Reddy's Labs gets zero obervations for Bollaram facility, EIR for Srikakulam facility Ruchika Sharma17 Jun 2023 12:10 PM ISTHyderabad: Dr Reddy's Labs has announced that the United States Food & Drug Administration (USFDA) has completed a GMP inspection at the...
Need well-designed protocol with statistically validated sample size: CDSCO panel tells Dr Reddy's Labs on Nerivio Isra Zaman6 Jun 2023 2:28 PM ISTIn line with the proposal to conduct a pivotal clinical investigation of the proposed product Nerivio, the Subject Expert Committee (SEC) functional...
Dr. Reddy gets CDSCO Panel Nod for comparative bioavailability study of Rabeprazole Modified Release capsule Dr. Divya Colin5 Jun 2023 6:00 PM ISTNew Delhi: Granting approval to Dr. Reddy's Laboratories for conducting the comparative bioavailability study of the proton pump inhibitor Rabeprazole...
Health Bulletin 5/June/2023 Isra Zaman5 Jun 2023 5:03 PM ISTHere are the top health stories for the day:Death of pregnant woman, unborn child: NCDRC holds Bengaluru hospital, anesthetist guilty of medical...
Tocilizumab biosimilar successfully meets primary, secondary endpoints in Phase I study: Dr Reddy's Labs Ruchika Sharma5 Jun 2023 2:00 PM ISTDr Reddy's is developing the proposed tocilizumab biosimilar as both intravenous and subcutaneous formulations.
Dr. Reddy's Gets CDSCO Panel Nod to study gastric acid blocker Vonoprazan fumarate Dr. Divya Colin1 Jun 2023 6:00 PM ISTNew Delhi: In line with the bioequivalence (BE) study report, the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Dr Reddy's Labs gets 4 USFDA observations for Srikakulam facility Ruchika Sharma13 May 2023 2:16 PM ISTHyderabad: Dr Reddy's Labs has announced that the United States Food & Drug Administration (USFDA) today completed a product-specific...
Dr Reddy's Labs reports nearly eleven-fold surge in Q4 profit Ruchika Sharma11 May 2023 1:30 PM ISTDr Reddy's consolidated revenue jumped 15.8 per cent to 62.97 billion rupees, while total operating expenses fell 13.3 per cent.
Dr Reddy's Labs unveils Regadenoson Injection in US Ruchika Sharma6 May 2023 2:30 PM ISTHyderabad: Drug major, Dr. Reddy's Laboratories Ltd. has announced the launch of Regadenoson Injection in the U.S. market, a generic therapeutic...
